PROBLEM TO BE SOLVED: To provide a new medical product for adjustment of weight loss and for prevention of weight gain, and for treatment and/or prevention of obesity or overweight.SOLUTION: A fatty acid composition containing at least either one or combination of an effective amount of (all -Zω-3)-5,8,11,14,17-eicosapentaenoic acid (EPA) and an effective amount of (all -Zω-3)-4,7,10,13,16,19-docosahexaenoic acid (DHA) is administered to a human or an animal.COPYRIGHT: (C)2013,JPO&INPIT【課題】体重減少を調節するため、体重増加を予防するためかつ肥満又は太りすぎの状態の治療及び/又は予防のための新規医療製品の提供。【解決手段】有効量の(全-Zオメガ-3)-5,8,11,14,17-エイコサペンタエン酸(EPA)及び(全-Zオメガ-3)-4,7,10,13,16,19-ドコサヘキサエン酸(DHA)の少なくとも1つ又はこれらのいずれかの組み合わせを含む脂肪酸組成物をヒト又は動物に投与する。【選択図】なし
